LifeArc

LifeArc is a pioneering medical research charity dedicated to transforming promising life science ideas into tangible medical breakthroughs that significantly improve patients’ lives. With a focus on early-stage translation, LifeArc expertly advances lab-based scientific discoveries to the crucial point where they can be developed into cutting-edge diagnostics, treatments, and cures. The primary address of LifeArc is 7-12 Tavistock Square, London, WC1H 9LT, GB, with additional locations at the Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, GB, and 9 Little France Road, Edinburgh, Scotland EH16 4, GB.

LifeArc operates as a self-funding entity with over 25 years of experience in the field. Its impactful work has already led to the creation of a diagnostic tool for antibiotic resistance and the successful licensing of four life-changing medicines. These include Keytruda® for cancer, Actemra® for rheumatoid arthritis, Tysabri® for multiple sclerosis, and Entyvio® for Crohn’s disease. LifeArc remains at the forefront of medical innovation, constantly striving to develop new solutions that address critical healthcare challenges.

LifeArc’s commitment to innovation and patient well-being makes it a key player in the medical research landscape. We invite the LifeArc's manager to create a customized and exclusive company showcase and product listing on our platform, and we look forward to showcasing the ongoing advancements and future achievements of LifeArc in the field of medical research.